These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17047173)

  • 1. Metabolic bone disease in patients receiving home parenteral nutrition: a Canadian study and review.
    Raman M; Aghdassi E; Baun M; Yeung M; Fairholm L; Saqui O; Allard JP
    JPEN J Parenter Enteral Nutr; 2006; 30(6):492-6. PubMed ID: 17047173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study.
    Cohen-Solal M; Baudoin C; Joly F; Vahedi K; D'Aoust L; De Vernejoul MC; Messing B
    J Bone Miner Res; 2003 Nov; 18(11):1989-94. PubMed ID: 14606511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition.
    Haderslev KV; Tjellesen L; Haderslev PH; Staun M
    JPEN J Parenter Enteral Nutr; 2004; 28(5):289-94. PubMed ID: 15449566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denosumab Improves Bone Mineral Density in Patients With Intestinal Failure Receiving Home Parenteral Nutrition: Results From a Randomized, Controlled Clinical Trial.
    Szczepanek K; Pedziwiatr M; Klek S
    JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):652-657. PubMed ID: 29187046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transversal study on the prevalence of Metabolic Bone Disease (MBD) and Home Parenteral Nutrition (HPN) in Spain: data from NADYA group].
    Martínez C; Virgili N; Cuerda C; Chicharro L; Gómez P; Moreno JM; Álvarez J; Martí E; Matía P; Penacho MA; Garde C; De Luis D; Gonzalo M; Lobo G;
    Nutr Hosp; 2010; 25(6):920-4. PubMed ID: 21519761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of bone disease in patients on home parenteral nutrition.
    Pironi L; Labate AM; Pertkiewicz M; Przedlacki J; Tjellesen L; Staun M; De Francesco A; Gallenca P; Guglielmi FW; Van Gossum A; Orlandoni P; Contaldo F; Villares JM;
    Clin Nutr; 2002 Aug; 21(4):289-96. PubMed ID: 12135588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Bone Mineralization Assessment in Children Treated With Long-Term Parenteral Nutrition for Severe Intestinal Failure.
    Poinsot P; Geoffroy P; Braillon P; Denis A; Loras-Duclaux I; Marotte S; Boutroy S; Bacchetta J; Touzet S; Lachaux A; Peretti N
    JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):613-622. PubMed ID: 28355492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic bone disease in children with intestinal failure is not associated with the level of parenteral nutrition dependency.
    Abi Nader E; Lambe C; Talbotec C; Acramel A; Pigneur B; Goulet O
    Clin Nutr; 2021 Apr; 40(4):1974-1982. PubMed ID: 32977995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with pamidronate for osteoporosis complicating long-term intestinal failure.
    Pastore S; Londero M; Barbieri F; Di Leo G; Paparazzo R; Ventura A
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):615-8. PubMed ID: 22614111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density in patients on home parenteral nutrition: a follow-up study.
    Pironi L; Tjellesen L; De Francesco A; Pertkiewicz M; Morselli Labate AM; Staun M; Przedlacki J; Lezo A; Orlandoni P; Pasanisi F;
    Clin Nutr; 2004 Dec; 23(6):1288-302. PubMed ID: 15556251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
    Monegal A; Guañabens N; Suárez MJ; Suárez F; Clemente G; García-González M; De la Mata M; Serrano T; Casafont F; Tome S; Barrios C; Navasa M
    Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Canadian Home Total Parenteral Nutrition (HTPN) Registry: vitamin K supplementation and bone mineral density.
    Aljarallah B; Fernandes G; Jeejeebhoy KN; Gramlich LM; Whittaker JS; Armstrong D; Duerksen DR; Allard JP
    JPEN J Parenter Enteral Nutr; 2012 Jul; 36(4):415-20. PubMed ID: 22301331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prevalence of Vitamin D Insufficiency and Deficiency and Their Relationship with Bone Mineral Density and Fracture Risk in Adults Receiving Long-Term Home Parenteral Nutrition.
    Napartivaumnuay N; Gramlich L
    Nutrients; 2017 May; 9(5):. PubMed ID: 28489034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of postoperative osteopenia using IV pamidronate: a pilot study.
    Hobby BD; Dominguez-Bartmess S; Szalay EA
    J Pediatr Orthop; 2013; 33(7):763-7. PubMed ID: 23872799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study.
    Plotkin H; Coughlin S; Kreikemeier R; Heldt K; Bruzoni M; Lerner G
    Dev Med Child Neurol; 2006 Sep; 48(9):709-12. PubMed ID: 16904014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pamidronate improves pain, wellbeing, fracture rate and bone density in 14 children and adolescents with chronic neurological conditions.
    Howe W; Davis E; Valentine J
    Dev Neurorehabil; 2010 Feb; 13(1):31-6. PubMed ID: 20067343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pamidronate treatment and posttreatment bone density in children with spastic quadriplegic cerebral palsy.
    Bachrach SJ; Kecskemethy HH; Harcke HT; Lark RK; Miller F; Henderson RC
    J Clin Densitom; 2006; 9(2):167-74. PubMed ID: 16785077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
    Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, social and rehabilitation status of long-term home parenteral nutrition patients: results of a European multicentre survey.
    Van Gossum A; Vahedi K; Abdel-Malik ; Staun M; Pertkiewicz M; Shaffer J; Hebuterne X; Beau P; Guedon C; Schmit A; Tjellesen L; Messing B; Forbes A;
    Clin Nutr; 2001 Jun; 20(3):205-10. PubMed ID: 11407866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.